News
Media
Conferences
Resources
Publications
Events
Business
Practice Type
Subscribe
Total Pharmacy

Jeff Cineas, PharmD Candidate

Articles by Jeff Cineas, PharmD Candidate

Erleada product image

Apalutimide for Prostate Cancer: What to Know

ByLisa M. Holle, PharmD, BCOP, FHOPA,Jeff Cineas, PharmD Candidate,Stephanie Trexler, PharmD Candidate

April 4th 2018

FDA approves apalutamide for castration-resistant prostate cancer.

Latest Updated Articles

Apalutimide for Prostate Cancer: What to Know
Published: April 4th 2018 | Updated:

Trending on Drug Topics

MDPNP Implementation Will Be Complex Despite Systems Properly in Place | NCPA 2025

Pharmacists Shifting from Reactive to Proactive Diabetes Counselors

Is it Safe for Birth Control Users to Go Years Without a Period?

© 2025 MJH Life Sciences^®

All rights reserved.